Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Vascular endothelial growth factor- C
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carc…
- Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation.
- Diagnostic and prognostic value of plasma cell-free DNA combined with VEGF-C in laryngeal squamous c…
- Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
- The Effect of Vascular Endothelial Growth Factor C and Adipose-Derived Stem Cells on Lymphatic Regen…
Most Relevant Clinical Trials
- Study the Novel Functions and Molecular Mechanisms of Vascular Endothelial Growth Factor-C (VEGF-C) …
- Vascular Endothelial Growth Factor Levels in Ectopic Pregnancy
- Vascular Endothelial Factor Gene Polymorphism in Preeclampsia
- Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
- Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Tr…
